Brian R. Walker
Endocrinology Unit
Queen's Medical Research Institute
Centre for Cardiovascular Science
University of Edinburgh
UK
Name/email consistency: high
- Glucocorticoids and cardiovascular disease. Walker, B.R. Eur. J. Endocrinol. (2007)
- Extra-adrenal regeneration of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1: physiological regulator and pharmacological target for energy partitioning. Walker, B.R. Proc. Nutr. Soc (2007)
- Cortisol--cause and cure for metabolic syndrome?. Walker, B.R. Diabet. Med. (2006)
- Tissue production of cortisol by 11beta-hydroxysteroid dehydrogenase type 1 and metabolic disease. Walker, B.R., Andrew, R. Ann. N. Y. Acad. Sci. (2006)
- Low birth weight predicts higher blood pressure but not dermal capillary density in two populations. Irving, R.J., Shore, A.C., Belton, N.R., Elton, R.A., Webb, D.J., Walker, B.R. Hypertension (2004)
- 11beta-hydroxysteroid dehydrogenase type 1 in obesity. Walker, B.R. Obes. Res. (2004)
- Is "Cushing's disease of the omentum" an affliction of mouse and men?. Walker, B.R. Diabetologia (2004)
- 11beta-hydroxysteroid dehydrogenase type 1 as a novel therapeutic target in metabolic and neurodegenerative disease. Walker, B.R., Seckl, J.R. Expert Opin. Ther. Targets (2003)
- Contrasting effects of intrauterine growth retardation and premature delivery on adult cortisol secretion and metabolism in man. Walker, B.R., Irving, R.J., Andrew, R., Belton, N.R. Clin. Endocrinol. (Oxf) (2002)
- Deflazacort: towards selective glucocorticoid receptor modulation?. Walker, B.R. Clin. Endocrinol. (Oxf) (2000)
- Endogenous inhibitors of 11beta-hydroxysteroid dehydrogenase type 1 do not explain abnormal cortisol metabolism in polycystic ovary syndrome. Walker, B.R., Rodin, A., Taylor, N.F., Clayton, R.N. Clin. Endocrinol. (Oxf) (2000)
- Independent effects of obesity and cortisol in predicting cardiovascular risk factors in men and women. Walker, B.R., Soderberg, S., Lindahl, B., Olsson, T. J. Intern. Med. (2000)
- Increased glucocorticoid activity in men with cardiovascular risk factors. Walker, B.R., Phillips, D.I., Noon, J.P., Panarelli, M., Andrew, R., Edwards, H.V., Holton, D.W., Seckl, J.R., Webb, D.J., Watt, G.C. Hypertension (1998)
- Growth hormone replacement inhibits renal and hepatic 11 beta-hydroxysteroid dehydrogenases in ACTH-deficient patients. Walker, B.R., Andrew, R., MacLeod, K.M., Padfield, P.L. Clin. Endocrinol. (Oxf) (1998)